• What Happens Next? Lab-Developed Test Rule Vacated: Bill Morice, M.D., Ph.D.

  • 2025/04/10
  • 再生時間: 12 分
  • ポッドキャスト

What Happens Next? Lab-Developed Test Rule Vacated: Bill Morice, M.D., Ph.D.

  • サマリー

  • In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss the recent court judgment on the U.S. Food and Drug Administration’s (FDA) oversight of lab-developed tests (LDT). They covered:

    • Details about the ruling to vacate the FDA’s rule on LDT oversight.
    • What LDT oversight might look like in the future.
    • How the laboratory medicine industry can help create an oversight approach that is positive for both patients and innovation.


    続きを読む 一部表示

あらすじ・解説

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss the recent court judgment on the U.S. Food and Drug Administration’s (FDA) oversight of lab-developed tests (LDT). They covered:

  • Details about the ruling to vacate the FDA’s rule on LDT oversight.
  • What LDT oversight might look like in the future.
  • How the laboratory medicine industry can help create an oversight approach that is positive for both patients and innovation.


What Happens Next? Lab-Developed Test Rule Vacated: Bill Morice, M.D., Ph.D.に寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。